Targeting a specific neural circuit through noninvasive neuromodulation may reduce symptoms in patients with posttraumatic stress disorder (PTSD), according to a recent study published in Nature Neuroscience.
Menu
Browsing: Psychiatry
Scientists have discovered a neuronal pathway involved in how the brain encodes the transition to high-intensity fear response behaviors required for survival, according to a study published in Nature.
A recent study published in Molecular Psychiatry has identified previously unknown alterations in neural connectivity that promote psychomotor disturbance — a slowing or reduction in movement — in individuals with major depressive disorder.
Investigators have identified new signaling mechanisms utilized by endocannabinoids to regulate a subset of neurons in response to stress, according to recent findings published in the Proceedings of the National Academy of Sciences.
A new Northwestern Medicine study has discovered that a key emotional brain center, the amygdala, releases endogenous cannabinoid molecules under stress, and these molecules dampen the incoming stress alarm from the hippocampus, a memory and emotion center in the brain.
Sexual minority women have a higher risk of postpartum depression but are less likely to have their sexual identities documented in electronic medical records, according to a Northwestern Medicine study published in JAMA Psychiatry.
The location of a brain lesion could give clues as to whether or not it will cause seizures later on in life, according to the findings of a new multicenter study published in JAMA Neurology.
Sandra Weintraub, PhD, professor of Psychiatry and Behavioral Sciences in the Division of Psychology and associate director of the Northwestern Alzheimer’s Disease Research Center in the Mesulam Center for Cognitive Neurology and Alzheimer’s Disease, was recently appointed to the Illinois Supreme Court Commission on Elder Law.
Targeting calcium signaling in neurons may represent a promising therapeutic approach for treating a rare form of schizophrenia, according to a Northwestern Medicine study.
Transgender and nonbinary youth experienced sustained improvements in depression and anxiety over two years after starting treatment with gender-affirming hormones, according to a recent study.